A New Clinical Spectrum for the Assessment of Nonalcoholic Fatty Liver Disease Using Intelligent Methods

Nonalcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease around the world. Remaining silent in the early stages makes its evaluation a challenge. Liver biopsy is still the gold standard method used to classify NAFLD stages but has important sample error issues and subjectivity in the interpretation. This research is an effort to overcome liver biopsy to a possible extent by forming a non-invasive clinical spectrum. This paper proposed an intelligent scheme using the forward algorithm, Viterbi algorithm, and Baum-welch algorithm for examining the disease, and a new clinical spectrum is introduced that incorporates most likely attributes associated with NAFLD stages. The experimental results verify that our method is efficient in distinguishing the credibility of an attribute being associated with a specific stage in case it is linked with more than one stage. Moreover, the proposed scheme can successfully estimate the likelihood of stage progression and supports medical knowledge more proficiently and realistically.

[1]  R. Xu,et al.  Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study , 2008, The American Journal of Gastroenterology.

[2]  Chun-Ling Chuang,et al.  A hybrid diagnosis model for determining the types of the liver disease , 2010, Comput. Biol. Medicine.

[3]  Wen Gao,et al.  A Chinese sign language recognition system based on SOFM/SRN/HMM , 2004, Pattern Recognit..

[4]  Pasi Luukka,et al.  Classification based on fuzzy robust PCA algorithms and similarity classifier , 2009, Expert Syst. Appl..

[5]  L. Rabiner,et al.  An introduction to hidden Markov models , 1986, IEEE ASSP Magazine.

[6]  Nicos Maglaveras,et al.  Fuzzy Hidden Markov Models: A New Approach In Multiple Sequence Alignment , 2006, MIE.

[7]  Nicos Maglaveras,et al.  Enhancing the Quality of Phylogenetic Analysis using Fuzzy Hidden Markov Model Alignments , 2007, MedInfo.

[8]  Paulo J. G. Lisboa,et al.  Bayesian Neural Network Applied in Medical Survival Analysis of Primary Biliary Cirrhosis , 2012, 2012 UKSim 14th International Conference on Computer Modelling and Simulation.

[9]  D. Haussler,et al.  Hidden Markov models in computational biology. Applications to protein modeling. , 1993, Journal of molecular biology.

[10]  Ying Peng,et al.  A hybrid approach of HMM and grey model for age-dependent health prediction of engineering assets , 2011, Expert Syst. Appl..

[11]  Olgierd Unold,et al.  Mining fuzzy rules using an Artificial Immune System with fuzzy partition learning , 2011, Appl. Soft Comput..

[12]  Chung-Lin Huang,et al.  Hand gesture recognition using a real-time tracking method and hidden Markov models , 2003, Image Vis. Comput..

[13]  F. Iber,et al.  Hepatology: A Textbook of Liver Disease , 1983 .

[14]  Sundaram Suresh,et al.  Meta-cognitive RBF Network and its Projection Based Learning algorithm for classification problems , 2013, Appl. Soft Comput..

[15]  Samuel S. Udoh,et al.  A framework for fuzzy diagnosis of hepatitis , 2011, 2011 World Congress on Information and Communication Technologies.

[16]  Jamil Ahmad,et al.  Diagnosis of liver disease induced by hepatitis virus using Artificial Neural Networks , 2011, 2011 IEEE 14th International Multitopic Conference.

[17]  Robert A Fisher,et al.  Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.

[18]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[19]  Bogdan Gabrys,et al.  Generalised bottom-up pruning: A model level combination of decision trees , 2012, Expert Syst. Appl..

[20]  Byung-Jun Yoon,et al.  Hidden Markov Models and their Applications in Biological Sequence Analysis , 2009, Current genomics.

[21]  A. Lonardo,et al.  Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? , 2018, Journal of hepatology.

[22]  Kemal Polat,et al.  Breast cancer and liver disorders classification using artificial immune recognition system (AIRS) with performance evaluation by fuzzy resource allocation mechanism , 2007, Expert Syst. Appl..

[23]  H. Noguchi,et al.  Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease , 2011, Experimental diabetes research.

[24]  Loo Chu Kiong,et al.  Autonomous and deterministic supervised fuzzy clustering with data imputation capabilities , 2011 .

[25]  A. Dhawan,et al.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. , 2014, World journal of gastroenterology.

[26]  David A. Elizondo,et al.  Linear separability and classification complexity , 2012, Expert Syst. Appl..

[27]  Lawrence R. Rabiner,et al.  A tutorial on hidden Markov models and selected applications in speech recognition , 1989, Proc. IEEE.

[28]  Nwe Ni Than,et al.  A concise review of non-alcoholic fatty liver disease. , 2015, Atherosclerosis.

[29]  Mark Stamp,et al.  A Revealing Introduction to Hidden Markov Models , 2017 .

[30]  Joarder Kamruzzaman,et al.  A hybrid of multiobjective Evolutionary Algorithm and HMM-Fuzzy model for time series prediction , 2012, Neurocomputing.

[31]  J. Fonseca,et al.  Comment to: "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease". , 2017, Journal of hepatology.

[32]  Chun-Ling Chuang,et al.  Case-based reasoning support for liver disease diagnosis , 2011, Artif. Intell. Medicine.

[33]  Ma Lizhuang,et al.  Correlation between Child-Pugh Degree and the Four Examinations of Traditional Chinese Medicine (TCM) with Liver Cirrhosis , 2008, BMEI 2008.

[34]  Kemal Polat,et al.  Medical decision support system based on artificial immune recognition immune system (AIRS), fuzzy weighted pre-processing and feature selection , 2007, Expert Syst. Appl..

[35]  Katsumi Yoshida,et al.  A comparison between two neural network rule extraction techniques for the diagnosis of hepatobiliary disorders , 2000, Artif. Intell. Medicine.

[36]  Rong-Ho Lin,et al.  An intelligent model for liver disease diagnosis , 2009, Artif. Intell. Medicine.

[37]  J. Schwimmer,et al.  Non-alcoholic fatty liver disease: epidemiology, pathophysiology, diagnosis and treatment , 2010 .

[38]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[39]  Vassilios Digalakis,et al.  Efficient speech recognition using subvector quantization and discrete-mixture HMMs , 1999, 1999 IEEE International Conference on Acoustics, Speech, and Signal Processing. Proceedings. ICASSP99 (Cat. No.99CH36258).

[40]  Zhen-Hua Ling,et al.  An Analysis of HMM-based prediction of articulatory movements , 2010, Speech Commun..

[41]  S. Kalra,et al.  Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). , 2013, The Journal of the Association of Physicians of India.

[42]  Hossein Pourghassem,et al.  Breast cancer detection using MRF-based probable texture feature and decision-level fusion-based classification using HMM on thermography images , 2016, Pattern Recognit..

[43]  César Hervás-Martínez,et al.  Multi-objective evolutionary algorithm for donor-recipient decision system in liver transplants , 2012, Eur. J. Oper. Res..

[44]  H. Cortez‐Pinto,et al.  Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. , 2013, Journal of hepatology.

[45]  M. Omata,et al.  Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma , 2020, International journal of molecular sciences.

[46]  Yoshihiko Nakamura,et al.  Spatio-temporal structure of human motion primitives and its application to motion prediction , 2016, Robotics Auton. Syst..

[47]  Z. Younossi,et al.  Evaluation and management of obesity-related nonalcoholic fatty liver disease , 2007, Nature Clinical Practice Gastroenterology &Hepatology.

[48]  Jun Zhou,et al.  Traffic Incident Prediction on Intersections Based on HMM , 2013 .

[49]  A. Lonardo,et al.  A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? , 2018, Acta Diabetologica.

[50]  Babita Pandey,et al.  Intelligent techniques and applications in liver disorders: a survey , 2014 .

[51]  S. Malnick,et al.  Non-alcoholic fatty liver disease - the heart of the matter. , 2015, World journal of hepatology.

[52]  Kemal Polat,et al.  A hybrid approach to medical decision support systems: Combining feature selection, fuzzy weighted pre-processing and AIRS , 2007, Comput. Methods Programs Biomed..

[53]  P. Paschos,et al.  Non alcoholic fatty liver disease and metabolic syndrome. , 2009, Hippokratia.

[54]  Yunis Torun,et al.  Designing simulated annealing and subtractive clustering based fuzzy classifier , 2011, Appl. Soft Comput..